Kenya

Kenya

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.95 (2.57 - 3.35) 2019 Modelled IHME
2.92 (2.54 - 3.32) 2018 Modelled IHME
2.92 (2.53 - 3.31) 2017 Modelled IHME
3.03 (2.63 - 3.43) 2016 Modelled IHME
3.19 (2.77 - 3.62) 2015 Modelled IHME
3.29 (2.86 - 3.74) 2014 Modelled IHME
3.38 (2.94 - 3.84) 2013 Modelled IHME
3.46 (3.01 - 3.94) 2012 Modelled IHME
3.54 (3.07 - 4.02) 2011 Modelled IHME
3.61 (3.13 - 4.10) 2010 Modelled IHME
3.69 (3.20 - 4.19) 2009 Modelled IHME
3.76 (3.27 - 4.28) 2008 Modelled IHME
3.83 (3.32 - 4.35) 2007 Modelled IHME
3.9 (3.38 - 4.43) 2006 Modelled IHME
3.95 (3.42 - 4.50) 2005 Modelled IHME
4 (3.46 - 4.56) 2004 Modelled IHME
4.05 (3.50 - 4.63) 2003 Modelled IHME
4.09 (3.54 - 4.69) 2002 Modelled IHME
4.12 (3.57 - 4.73) 2001 Modelled IHME
4.13 (3.57 - 4.74) 2000 Modelled IHME
4.13 (3.57 - 4.74) 1999 Modelled IHME
4.12 (3.57 - 4.73) 1998 Modelled IHME
4.1 (3.57 - 4.71) 1997 Modelled IHME
4.09 (3.55 - 4.69) 1996 Modelled IHME
4.07 (3.54 - 4.67) 1995 Modelled IHME
4.06 (3.52 - 4.64) 1994 Modelled IHME
4.04 (3.50 - 4.62) 1993 Modelled IHME
4.01 (3.49 - 4.60) 1992 Modelled IHME
3.99 (3.46 - 4.57) 1991 Modelled IHME
3.96 (3.44 - 4.53) 1990 Modelled IHME
2.17 (1.63 - 2.85) 2015 Modelled WHO
1.2 (0.90 - 1.50) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.54 (0.43 - 0.67) 2019 Modelled IHME
0.56 (0.45 - 0.70) 2018 Modelled IHME
0.57 (0.45 - 0.70) 2017 Modelled IHME
0.53 (0.42 - 0.66) 2016 Modelled IHME
0.48 (0.38 - 0.60) 2015 Modelled IHME
0.47 (0.37 - 0.58) 2014 Modelled IHME
0.46 (0.36 - 0.56) 2013 Modelled IHME
0.45 (0.36 - 0.55) 2012 Modelled IHME
0.44 (0.35 - 0.55) 2011 Modelled IHME
0.44 (0.35 - 0.54) 2010 Modelled IHME
0.44 (0.35 - 0.55) 2009 Modelled IHME
0.45 (0.36 - 0.55) 2008 Modelled IHME
0.46 (0.36 - 0.56) 2007 Modelled IHME
0.47 (0.37 - 0.58) 2006 Modelled IHME
0.49 (0.39 - 0.60) 2005 Modelled IHME
0.65 (0.51 - 0.80) 2004 Modelled IHME
1 (0.80 - 1.25) 2003 Modelled IHME
1.42 (1.13 - 1.77) 2002 Modelled IHME
1.77 (1.41 - 2.21) 2001 Modelled IHME
1.92 (1.52 - 2.39) 2000 Modelled IHME
1.92 (1.53 - 2.39) 1999 Modelled IHME
1.92 (1.52 - 2.38) 1998 Modelled IHME
1.91 (1.52 - 2.38) 1997 Modelled IHME
1.91 (1.52 - 2.38) 1996 Modelled IHME
1.9 (1.52 - 2.37) 1995 Modelled IHME
1.9 (1.51 - 2.37) 1994 Modelled IHME
1.89 (1.51 - 2.36) 1993 Modelled IHME
1.89 (1.50 - 2.35) 1992 Modelled IHME
1.88 (1.50 - 2.34) 1991 Modelled IHME
1.87 (1.49 - 2.32) 1990 Modelled IHME
0.86 (0.60 - 1.22) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
919,115 (798,000 - 1,050,420) 1990 Modelled IHME
954,830 (828,517 - 1,093,570) 1991 Modelled IHME
990,895 (860,832 - 1,136,250) 1992 Modelled IHME
1,027,100 (891,598 - 1,175,890) 1993 Modelled IHME
1,063,270 (922,367 - 1,217,340) 1994 Modelled IHME
1,099,290 (954,311 - 1,259,200) 1995 Modelled IHME
1,135,670 (986,943 - 1,301,800) 1996 Modelled IHME
1,172,700 (1,019,180 - 1,345,280) 1997 Modelled IHME
1,209,870 (1,050,140 - 1,388,920) 1998 Modelled IHME
1,246,730 (1,080,140 - 1,431,980) 1999 Modelled IHME
1,282,740 (1,110,520 - 1,473,640) 2000 Modelled IHME
1,314,980 (1,138,570 - 1,509,730) 2001 Modelled IHME
1,341,820 (1,161,760 - 1,537,930) 2002 Modelled IHME
1,364,780 (1,181,670 - 1,560,890) 2003 Modelled IHME
1,385,590 (1,199,690 - 1,580,780) 2004 Modelled IHME
1,406,280 (1,219,550 - 1,600,960) 2005 Modelled IHME
1,425,310 (1,236,790 - 1,621,240) 2006 Modelled IHME
1,440,260 (1,248,550 - 1,635,690) 2007 Modelled IHME
1,451,870 (1,261,240 - 1,650,430) 2008 Modelled IHME
1,461,030 (1,268,440 - 1,662,670) 2009 Modelled IHME
1,468,810 (1,274,500 - 1,669,440) 2010 Modelled IHME
1,475,880 (1,280,740 - 1,677,410) 2011 Modelled IHME
1,481,060 (1,286,210 - 1,684,680) 2012 Modelled IHME
1,482,640 (1,287,460 - 1,686,130) 2013 Modelled IHME
1,478,760 (1,283,900 - 1,681,440) 2014 Modelled IHME
1,467,510 (1,275,110 - 1,666,730) 2015 Modelled IHME
1,424,370 (1,236,230 - 1,616,070) 2016 Modelled IHME
1,403,520 (1,219,550 - 1,594,830) 2017 Modelled IHME
1,436,480 (1,248,360 - 1,630,340) 2018 Modelled IHME
1,483,490 (1,292,280 - 1,682,230) 2019 Modelled IHME
559,000 (421,000 - 749,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.16 (4.41 - 8.81) 2019 Modelled IHME
6.1 (4.43 - 8.73) 2018 Modelled IHME
6.08 (4.41 - 8.59) 2017 Modelled IHME
6.04 (4.46 - 8.63) 2016 Modelled IHME
6.11 (4.53 - 8.72) 2015 Modelled IHME
6.48 (4.86 - 9.28) 2014 Modelled IHME
7.2 (5.43 - 10.20) 2013 Modelled IHME
8 (6.09 - 11.20) 2012 Modelled IHME
8.63 (6.43 - 12) 2011 Modelled IHME
8.88 (6.72 - 12.40) 2010 Modelled IHME
8.81 (6.65 - 12.30) 2009 Modelled IHME
8.73 (6.65 - 12.10) 2008 Modelled IHME
8.63 (6.60 - 12) 2007 Modelled IHME
8.52 (6.52 - 11.90) 2006 Modelled IHME
8.38 (6.42 - 11.70) 2005 Modelled IHME
8.19 (6.28 - 11.40) 2004 Modelled IHME
8.01 (6.05 - 11.40) 2003 Modelled IHME
7.78 (5.87 - 11.10) 2002 Modelled IHME
7.57 (5.58 - 11.10) 2001 Modelled IHME
7.48 (5.49 - 10.90) 2000 Modelled IHME
7.32 (5.31 - 10.80) 1999 Modelled IHME
7.28 (5.11 - 10.90) 1998 Modelled IHME
7.18 (5.03 - 10.80) 1997 Modelled IHME
7.12 (4.85 - 10.90) 1996 Modelled IHME
7.07 (4.82 - 11) 1995 Modelled IHME
7.04 (4.77 - 11.10) 1994 Modelled IHME
7.01 (4.72 - 11.20) 1993 Modelled IHME
6.98 (4.57 - 11.30) 1992 Modelled IHME
6.9 (4.46 - 11.30) 1991 Modelled IHME
6.82 (4.34 - 11.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3,092 (2,217 - 4,427) 2019 Modelled IHME
3,000 (2,179 - 4,293) 2018 Modelled IHME
2,924 (2,124 - 4,134) 2017 Modelled IHME
2,840 (2,097 - 4,062) 2016 Modelled IHME
2,811 (2,086 - 4,009) 2015 Modelled IHME
2,914 (2,183 - 4,169) 2014 Modelled IHME
3,156 (2,382 - 4,478) 2013 Modelled IHME
3,423 (2,606 - 4,786) 2012 Modelled IHME
3,604 (2,684 - 5,025) 2011 Modelled IHME
3,614 (2,733 - 5,024) 2010 Modelled IHME
3,493 (2,635 - 4,857) 2009 Modelled IHME
3,371 (2,567 - 4,670) 2008 Modelled IHME
3,244 (2,480 - 4,520) 2007 Modelled IHME
3,119 (2,385 - 4,367) 2006 Modelled IHME
2,984 (2,286 - 4,174) 2005 Modelled IHME
2,838 (2,177 - 3,955) 2004 Modelled IHME
2,701 (2,039 - 3,861) 2003 Modelled IHME
2,554 (1,926 - 3,655) 2002 Modelled IHME
2,418 (1,783 - 3,541) 2001 Modelled IHME
2,325 (1,705 - 3,391) 2000 Modelled IHME
2,211 (1,606 - 3,268) 1999 Modelled IHME
2,138 (1,503 - 3,199) 1998 Modelled IHME
2,053 (1,437 - 3,084) 1997 Modelled IHME
1,978 (1,347 - 3,035) 1996 Modelled IHME
1,909 (1,300 - 2,967) 1995 Modelled IHME
1,846 (1,249 - 2,911) 1994 Modelled IHME
1,784 (1,202 - 2,845) 1993 Modelled IHME
1,724 (1,129 - 2,794) 1992 Modelled IHME
1,652 (1,067 - 2,705) 1991 Modelled IHME
1,583 (1,007 - 2,634) 1990 Modelled IHME
1,388 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
29 (25 - 33) 2019 Modelled IHME
29 (25 - 33) 2018 Modelled IHME
29 (25 - 33) 2017 Modelled IHME
29 (25 - 33) 2016 Modelled IHME
29 (25 - 33) 2015 Modelled IHME
29 (25 - 33) 2014 Modelled IHME
29 (26 - 33) 2013 Modelled IHME
30 (26 - 34) 2012 Modelled IHME
30 (26 - 34) 2011 Modelled IHME
30 (26 - 34) 2010 Modelled IHME
30 (26 - 34) 2009 Modelled IHME
30 (26 - 34) 2008 Modelled IHME
30 (26 - 34) 2007 Modelled IHME
30 (26 - 34) 2006 Modelled IHME
30 (26 - 34) 2005 Modelled IHME
30 (26 - 34) 2004 Modelled IHME
30 (26 - 34) 2003 Modelled IHME
30 (26 - 34) 2002 Modelled IHME
30 (26 - 34) 2001 Modelled IHME
30 (26 - 34) 2000 Modelled IHME
29 (26 - 34) 1999 Modelled IHME
29 (26 - 34) 1998 Modelled IHME
29 (26 - 34) 1997 Modelled IHME
29 (26 - 34) 1996 Modelled IHME
29 (25 - 33) 1995 Modelled IHME
29 (25 - 33) 1994 Modelled IHME
29 (25 - 33) 1993 Modelled IHME
28 (24 - 32) 1992 Modelled IHME
28 (24 - 32) 1991 Modelled IHME
28 (23 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
92 2018 Survey/reported WHO/UNICEF
82 2017 Survey/reported WHO/UNICEF
89 2016 Survey/reported WHO/UNICEF
89 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
94 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
88 2009 Survey/reported WHO/UNICEF
88 2008 Survey/reported WHO/UNICEF
81 2007 Survey/reported WHO/UNICEF
80 2006 Survey/reported WHO/UNICEF
76 2005 Survey/reported WHO/UNICEF
73 2004 Survey/reported WHO/UNICEF
73 2003 Survey/reported WHO/UNICEF
84 2002 Survey/reported WHO/UNICEF
92 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
9 (5 - 31) 2014 Survey/reported Kenya National AIDS Control Council, 2014
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.21 (0.97 - 1.53) 2019 Modelled IHME
1.21 (0.96 - 1.52) 2018 Modelled IHME
1.2 (0.96 - 1.51) 2017 Modelled IHME
1.18 (0.94 - 1.49) 2016 Modelled IHME
1.17 (0.93 - 1.48) 2015 Modelled IHME
1.17 (0.94 - 1.48) 2014 Modelled IHME
1.17 (0.94 - 1.48) 2013 Modelled IHME
1.17 (0.93 - 1.48) 2012 Modelled IHME
1.17 (0.93 - 1.48) 2011 Modelled IHME
1.17 (0.93 - 1.48) 2010 Modelled IHME
1.17 (0.93 - 1.48) 2009 Modelled IHME
1.17 (0.93 - 1.48) 2008 Modelled IHME
1.17 (0.94 - 1.48) 2007 Modelled IHME
1.18 (0.94 - 1.48) 2006 Modelled IHME
1.18 (0.94 - 1.48) 2005 Modelled IHME
1.18 (0.94 - 1.49) 2004 Modelled IHME
1.19 (0.95 - 1.50) 2003 Modelled IHME
1.19 (0.95 - 1.50) 2002 Modelled IHME
1.2 (0.95 - 1.51) 2001 Modelled IHME
1.2 (0.96 - 1.52) 2000 Modelled IHME
1.2 (0.95 - 1.52) 1999 Modelled IHME
1.2 (0.95 - 1.51) 1998 Modelled IHME
1.2 (0.95 - 1.51) 1997 Modelled IHME
1.2 (0.95 - 1.51) 1996 Modelled IHME
1.2 (0.95 - 1.51) 1995 Modelled IHME
1.2 (0.95 - 1.51) 1994 Modelled IHME
1.2 (0.96 - 1.51) 1993 Modelled IHME
1.21 (0.96 - 1.52) 1992 Modelled IHME
1.22 (0.97 - 1.54) 1991 Modelled IHME
1.23 (0.97 - 1.56) 1990 Modelled IHME
0.2 (0.20 - 0.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
16.4 (10.90 - 23.30) 2013 Survey/reported Mwatelah RS et al, 2015
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
285,449 (225,745 - 361,879) 1990 Modelled IHME
291,978 (231,540 - 368,566) 1991 Modelled IHME
298,741 (237,687 - 376,248) 1992 Modelled IHME
305,932 (243,520 - 385,254) 1993 Modelled IHME
313,784 (250,057 - 395,833) 1994 Modelled IHME
322,574 (256,690 - 406,442) 1995 Modelled IHME
332,122 (264,556 - 418,645) 1996 Modelled IHME
341,978 (272,497 - 431,539) 1997 Modelled IHME
352,056 (280,416 - 444,720) 1998 Modelled IHME
362,283 (288,490 - 458,075) 1999 Modelled IHME
372,567 (296,732 - 471,026) 2000 Modelled IHME
382,323 (304,666 - 483,024) 2001 Modelled IHME
391,343 (312,106 - 493,963) 2002 Modelled IHME
400,114 (319,283 - 504,366) 2003 Modelled IHME
409,198 (326,646 - 515,283) 2004 Modelled IHME
419,237 (334,624 - 527,771) 2005 Modelled IHME
430,142 (343,088 - 541,766) 2006 Modelled IHME
441,375 (351,619 - 556,194) 2007 Modelled IHME
452,907 (360,710 - 571,023) 2008 Modelled IHME
464,716 (370,108 - 586,202) 2009 Modelled IHME
476,791 (379,858 - 600,977) 2010 Modelled IHME
489,043 (390,062 - 616,543) 2011 Modelled IHME
501,385 (399,618 - 632,799) 2012 Modelled IHME
513,803 (410,501 - 648,806) 2013 Modelled IHME
526,294 (420,684 - 663,865) 2014 Modelled IHME
538,877 (429,813 - 680,330) 2015 Modelled IHME
556,231 (444,090 - 702,831) 2016 Modelled IHME
575,875 (460,013 - 727,421) 2017 Modelled IHME
592,649 (473,235 - 748,253) 2018 Modelled IHME
608,573 (484,891 - 769,842) 2019 Modelled IHME
115,000 (42,000 - 126,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.02 (4.86 - 10.10) 2019 Modelled IHME
7.08 (4.82 - 10) 2018 Modelled IHME
7.08 (4.91 - 10) 2017 Modelled IHME
6.96 (4.93 - 9.96) 2016 Modelled IHME
6.92 (4.94 - 9.83) 2015 Modelled IHME
6.88 (4.87 - 9.74) 2014 Modelled IHME
6.74 (4.87 - 9.46) 2013 Modelled IHME
6.59 (4.77 - 9.08) 2012 Modelled IHME
6.46 (4.68 - 8.88) 2011 Modelled IHME
6.41 (4.64 - 8.76) 2010 Modelled IHME
6.37 (4.61 - 8.68) 2009 Modelled IHME
6.35 (4.65 - 8.72) 2008 Modelled IHME
6.33 (4.62 - 8.63) 2007 Modelled IHME
6.3 (4.63 - 8.65) 2006 Modelled IHME
6.24 (4.61 - 8.60) 2005 Modelled IHME
6.15 (4.60 - 8.44) 2004 Modelled IHME
6.1 (4.50 - 8.56) 2003 Modelled IHME
6 (4.39 - 8.52) 2002 Modelled IHME
5.9 (4.23 - 8.45) 2001 Modelled IHME
5.88 (4.18 - 8.45) 2000 Modelled IHME
5.76 (4.01 - 8.39) 1999 Modelled IHME
5.74 (3.95 - 8.43) 1998 Modelled IHME
5.68 (3.86 - 8.43) 1997 Modelled IHME
5.64 (3.77 - 8.41) 1996 Modelled IHME
5.61 (3.72 - 8.61) 1995 Modelled IHME
5.61 (3.68 - 8.59) 1994 Modelled IHME
5.6 (3.62 - 8.72) 1993 Modelled IHME
5.61 (3.57 - 8.74) 1992 Modelled IHME
5.57 (3.54 - 8.71) 1991 Modelled IHME
5.54 (3.46 - 9.02) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
3,526 (2,442 - 5,071) 2019 Modelled IHME
3,482 (2,370 - 4,929) 2018 Modelled IHME
3,408 (2,360 - 4,813) 2017 Modelled IHME
3,275 (2,318 - 4,687) 2016 Modelled IHME
3,184 (2,271 - 4,522) 2015 Modelled IHME
3,090 (2,190 - 4,378) 2014 Modelled IHME
2,957 (2,134 - 4,149) 2013 Modelled IHME
2,820 (2,043 - 3,888) 2012 Modelled IHME
2,698 (1,954 - 3,707) 2011 Modelled IHME
2,607 (1,888 - 3,562) 2010 Modelled IHME
2,525 (1,827 - 3,439) 2009 Modelled IHME
2,451 (1,794 - 3,365) 2008 Modelled IHME
2,378 (1,735 - 3,242) 2007 Modelled IHME
2,304 (1,695 - 3,165) 2006 Modelled IHME
2,222 (1,642 - 3,061) 2005 Modelled IHME
2,132 (1,593 - 2,927) 2004 Modelled IHME
2,057 (1,519 - 2,887) 2003 Modelled IHME
1,971 (1,440 - 2,798) 2002 Modelled IHME
1,885 (1,351 - 2,699) 2001 Modelled IHME
1,825 (1,300 - 2,626) 2000 Modelled IHME
1,742 (1,212 - 2,535) 1999 Modelled IHME
1,688 (1,161 - 2,477) 1998 Modelled IHME
1,624 (1,103 - 2,410) 1997 Modelled IHME
1,567 (1,046 - 2,336) 1996 Modelled IHME
1,515 (1,005 - 2,323) 1995 Modelled IHME
1,469 (965 - 2,250) 1994 Modelled IHME
1,426 (922 - 2,218) 1993 Modelled IHME
1,384 (880 - 2,158) 1992 Modelled IHME
1,334 (846 - 2,084) 1991 Modelled IHME
1,285 (803 - 2,091) 1990 Modelled IHME
743 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
21 (18 - 25) 2019 Modelled IHME
21 (18 - 25) 2018 Modelled IHME
21 (18 - 25) 2017 Modelled IHME
21 (18 - 25) 2016 Modelled IHME
21 (18 - 24) 2015 Modelled IHME
21 (18 - 24) 2014 Modelled IHME
21 (18 - 24) 2013 Modelled IHME
21 (18 - 24) 2012 Modelled IHME
21 (17 - 24) 2011 Modelled IHME
21 (17 - 24) 2010 Modelled IHME
21 (17 - 24) 2009 Modelled IHME
20 (17 - 24) 2008 Modelled IHME
20 (17 - 24) 2007 Modelled IHME
20 (17 - 24) 2006 Modelled IHME
20 (17 - 24) 2005 Modelled IHME
20 (17 - 23) 2004 Modelled IHME
20 (17 - 24) 2003 Modelled IHME
20 (17 - 23) 2002 Modelled IHME
20 (17 - 23) 2001 Modelled IHME
20 (17 - 23) 2000 Modelled IHME
20 (17 - 23) 1999 Modelled IHME
20 (17 - 23) 1998 Modelled IHME
20 (17 - 23) 1997 Modelled IHME
20 (17 - 24) 1996 Modelled IHME
20 (17 - 24) 1995 Modelled IHME
20 (17 - 24) 1994 Modelled IHME
20 (17 - 24) 1993 Modelled IHME
21 (17 - 24) 1992 Modelled IHME
21 (17 - 24) 1991 Modelled IHME
21 (18 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
9 (5 - 31) 2014 Survey/reported Kenya National AIDS Control Council, 2014
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3,092
2019
(2,217 - 4,427)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
3,526
2019
(2,442 - 5,071)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
9
2014
(5 - 31)
Kenya National AIDS Control Council, 2014
Eligible for HBV generic medicines
Eligible for HCV generic medicines